Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. DOCS
DOCS logo

DOCS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
25.190
Open
24.960
VWAP
24.68
Vol
1.94M
Mkt Cap
4.55B
Low
24.200
Amount
47.88M
EV/EBITDA(TTM)
15.12
Total Shares
184.71M
EV
3.84B
EV/OCF(TTM)
12.18
P/S(TTM)
7.81
Doximity, Inc. provides a digital platform for the United States medical professionals. It offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
Show More

Events Timeline

(ET)
2026-02-06
16:50:00
Dow Surges Above 50,000 for First Time, Amazon Shares Drop Post Earnings
select
2026-02-06
12:10:00
Doximity Shares Drop 24.7% to $25.10
select
2026-02-06
12:00:00
Major Averages Rebound as Amazon Slides
select
2026-02-06
10:10:00
Doximity Shares Drop 26.2% to $24.59
select

News

NASDAQ.COM
8.0
03-09NASDAQ.COM
Analysis of DOCS Options Contracts and Investment Opportunities
  • Put Option Appeal: The current bid for the $22.50 put option is $2.15, and if an investor sells this contract, they commit to buying shares at $22.50, resulting in a cost basis of $20.35, which is approximately a 10% discount from the current price of $24.95, making it attractive for those interested in DOCS.
  • Yield Potential: Should the put option expire worthless, the premium would yield a 9.56% return on the cash commitment, or an annualized return of 12.28%, known as YieldBoost, highlighting the potential attractiveness of this investment strategy.
  • Call Option Returns: The $30.00 call option has a current bid of $2.55, and if an investor buys DOCS shares at $24.95 and sells this call, they could achieve a total return of 30.46% if the stock is called away at expiration, showcasing the high return potential of this strategy.
  • Risk Assessment: Current data indicates a 47% chance that the $30.00 call option may expire worthless, allowing investors to retain both their shares and the premium collected, further enhancing the safety and profitability of the investment.
Fool
2.0
02-23Fool
Doximity Stock Hits Low Amid AI Disruption Fears
  • Market Reaction: Software stocks have been severely impacted by fears of AI disruption, with some stocks dropping 50% in just a few months, creating buying opportunities for high-quality businesses.
  • Doximity Performance: Doximity's stock has fallen 66% over the past year and is trading near all-time lows, yet its underlying business remains strong, indicating robust competitiveness in the healthcare market.
  • Revenue Growth: Doximity has experienced a phenomenal revenue increase of 448% since March 2020, although the latest quarter saw a slowdown to 10% year-over-year growth, suggesting significant potential within its existing medical marketing tools.
  • Profitability: With an EBIT margin of 38.5%, Doximity stands out as best-in-class among software providers, and its price-to-earnings ratio of 21 indicates potential investment value amidst the current AI-induced market dip.
NASDAQ.COM
2.0
02-23NASDAQ.COM
Doximity Stock Declines Amid Software Stock Bust
  • Market Performance: Doximity's stock has plummeted 66% during the 2026 software stock bust, trading near all-time lows despite strong profitability, indicating market concerns about its future prospects.
  • Solid Customer Base: With 126 customers spending over $500,000 annually on the platform and 85% of U.S. physicians using it, Doximity demonstrates a strong lock on the medical social media market.
  • Slowing Revenue Growth: Revenue has surged 448% since March 2020, but the latest quarter saw only 10% year-over-year growth, highlighting significant potential for further expansion within existing medical marketing tools.
  • Strong Profitability: Doximity boasts a 38.5% EBIT margin, best-in-class for software providers, and trades at a price-to-earnings ratio of 21, positioning it as a potential growth stock for investors during the AI-fear dip.
Globenewswire
7.0
02-12Globenewswire
Investigation into Doximity Executives for Breach of Fiduciary Duties
  • Legal Investigation Initiated: Halper Sadeh LLC is investigating whether certain Doximity Inc. executives breached their fiduciary duties to shareholders, which could impact corporate governance and shareholder rights.
  • Shareholder Rights Protection: Long-term Doximity shareholders may seek corporate governance reforms, fund recovery, and court-approved financial incentives, aimed at enhancing company transparency and accountability.
  • Legal Fee Arrangement: The firm will handle the case on a contingent fee basis, meaning shareholders will not incur out-of-pocket legal expenses, reducing the financial burden and encouraging broader participation.
  • Improving Corporate Governance: Shareholder involvement can help enhance company policies and oversight mechanisms, thereby increasing shareholder value; Halper Sadeh LLC has extensive experience in driving corporate reforms and recovering funds.
Fool
6.5
02-09Fool
William Blair Reduces Doximity Stake by $20.89 Million
  • Share Reduction Details: According to a SEC filing dated February 9, 2026, William Blair reduced its Doximity stake by 372,184 shares during Q4 2025, with an estimated transaction value of $20.89 million, indicating a waning confidence in the company.
  • Market Value and Performance Impact: The quarter-end value of Doximity's stake decreased by $184.77 million, primarily due to stock price declines and share sales, highlighting the company's poor market performance, particularly with its stock down 66% year-over-year.
  • Investor Focus: Although this sale accounted for only 15% of William Blair's holdings, investors should closely monitor the firm's future stock strategy, especially as Doximity trades at its lowest valuation in history.
  • Market Outlook Analysis: Despite a slowdown in sales growth to 10%, Doximity's potential in the pharmaceutical advertising market remains strong, with a full launch of AI applications expected in 2026, which could provide new growth momentum for the company.
NASDAQ.COM
2.0
02-09NASDAQ.COM
William Blair Reduces Doximity Holdings
  • Reduction in Holdings: William Blair sold 372,184 shares of Doximity in Q4 2025, with an estimated transaction value of $20.89 million, indicating a potential decline in confidence regarding the stock's future performance.
  • Decline in Position Value: The quarter-end value of Doximity's holdings decreased by $184.77 million, reflecting both trading activities and stock price movements, suggesting a weakening market outlook for the company.
  • Change in Asset Allocation: Post-sale, Doximity represented only 0.67% of William Blair's assets under management, indicating a diminished significance of the stock within the fund and potentially lowering investor interest.
  • Poor Market Performance: As of February 6, 2026, Doximity shares were priced at $27.73, down 66% year-over-year and significantly underperforming the S&P 500, highlighting increasing competitive pressures in the healthcare information services sector.
Wall Street analysts forecast DOCS stock price to rise
18 Analyst Rating
Wall Street analysts forecast DOCS stock price to rise
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
25.00
Averages
42.75
High
63.00
Current: 0.000
sliders
Low
25.00
Averages
42.75
High
63.00
JPMorgan
Neutral
downgrade
$40 -> $33
AI Analysis
2026-02-20
Reason
JPMorgan
Price Target
$40 -> $33
AI Analysis
2026-02-20
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Doximity to $33 from $40 and keeps a Neutral rating on the shares.
Piper Sandler
Overweight
maintain
$40 -> $42
2026-02-20
Reason
Piper Sandler
Price Target
$40 -> $42
2026-02-20
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Doximity to $42 from $40 and keeps an Overweight rating on the shares. The firm had the opportunity to demo Doximity's AI tool suite last week in a session hosted by CEO Jeff Tangney. DoxGPT stands out for three reasons, in Piper's view. First for its synergistic position within the Doximity ecosystem; second for the quality and accuracy of its clinical reference responses; and finally for the evidence base supporting its medical AI.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DOCS
Unlock Now

Valuation Metrics

The current forward P/E ratio for Doximity Inc (DOCS.N) is 27.21, compared to its 5-year average forward P/E of 56.72. For a more detailed relative valuation and DCF analysis to assess Doximity Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
56.72
Current PE
27.21
Overvalued PE
102.98
Undervalued PE
10.46

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
37.46
Current EV/EBITDA
19.84
Overvalued EV/EBITDA
66.55
Undervalued EV/EBITDA
8.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
17.43
Current PS
12.06
Overvalued PS
26.56
Undervalued PS
8.31

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

current bullish rsi divergences
Intellectia · 213 candidates
Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
NVO logo
NVO
Novo Nordisk A/S
170.38B
MELI logo
MELI
MercadoLibre Inc
89.62B
NTES logo
NTES
NetEase Inc
73.21B
ET logo
ET
Energy Transfer LP
63.96B
BIDU logo
BIDU
Baidu Inc
45.60B
TCOM logo
TCOM
Trip.com Group Ltd
35.00B
best stocks to short now
Intellectia · 7 candidates
Market Cap: >= 1000.00MRegion: USPrice: $3.00 - $250.00Analyst Consensus: Moderate Buy, Hold, Moderate Sell, Strong SellQuarter Eps Yoy Growth: <= 0.0%Pe Ttm: >= 30List Exchange: XNYS, XNAS, XASEPs Ratio: >= 6.00Quarter Price Change Pct: <= $-8.00Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
CSGP logo
CSGP
CoStar Group Inc
19.08B
EW logo
EW
Edwards Lifesciences Corp
44.36B
LEU logo
LEU
Centrus Energy Corp
3.64B
SOFI logo
SOFI
SoFi Technologies Inc
24.52B
SHOP logo
SHOP
Shopify Inc
144.31B
DOCS logo
DOCS
Doximity Inc
4.56B
biggest loser in stock market this week
Intellectia · 18 candidates
Market Cap: >= 300.00MList Exchange: XNYS, XNAS, XASEWeek Price Change Pct: <= $-20.00Monthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
KD logo
KD
Kyndryl Holdings Inc
2.54B
FLNC logo
FLNC
Fluence Energy Inc
3.49B
MOH logo
MOH
Molina Healthcare Inc
6.40B
HIMS logo
HIMS
Hims & Hers Health Inc
3.92B
MNDY logo
MNDY
monday.com Ltd
3.82B
PI logo
PI
Impinj Inc
3.34B
10 top oversold stocks
Intellectia · 58 candidates
Market Cap: >= 5.00BRegion: USPrice: >= $5.00Rsi Category: oversoldList Exchange: XNYS, XNAS, XASEMonth Price Change Pct: <= $-20.00Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
U logo
U
Unity Software Inc
10.01B
RDDT logo
RDDT
Reddit Inc
27.07B
HUBS logo
HUBS
HubSpot Inc
12.12B
APP logo
APP
Applovin Corp
137.11B
IT logo
IT
Gartner Inc
11.15B
DOCS logo
DOCS
Doximity Inc
5.06B
Growth stocks to invest in
Intellectia · 24 candidates
Market Cap: >= 5.00BRegion: USQuarter Revenue Yoy Growth: >= 20.0%Market Cap Category: large, midRevenue 5yr Cagr: >= 15Eps 5yr Cagr: >= 15List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
CELH logo
CELH
Celsius Holdings Inc
13.94B
FUTU logo
FUTU
Futu Holdings Ltd
22.82B
DOCS logo
DOCS
Doximity Inc
7.33B
ATAT logo
ATAT
Atour Lifestyle Holdings Ltd
5.01B
AXON logo
AXON
Axon Enterprise Inc
45.20B
GMAB logo
GMAB
Genmab A/S
20.27B
What stock has the most upside this 2026?
Intellectia · 48 candidates
Market Cap: 1000.00M - 100.00BAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 10List Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePrice
Ticker
Name
Market Cap$
top bottom
KSPI logo
KSPI
Kaspi.kz AO
15.02B
QFIN logo
QFIN
Qfin Holdings Inc
2.14B
NICE logo
NICE
Nice Ltd
7.07B
PTC logo
PTC
PTC Inc
19.28B
JD logo
JD
JD.com Inc
42.34B
TW logo
TW
Tradeweb Markets Inc
24.31B
best stocks to invest in 2026 q1
Intellectia · 21 candidates
Market Cap: >= 5.00BMarket Cap Category: large, midAnalyst Consensus: Strong Buy, Moderate BuyReturn On Equity: >= 12.0%Target Price Upside Potential: MoreAbovePriceOne Month Predict Return: >= 5.0%
Ticker
Name
Market Cap$
top bottom
MORN logo
MORN
Morningstar Inc
8.63B
KSPI logo
KSPI
Kaspi.kz AO
14.51B
MANH logo
MANH
Manhattan Associates Inc
10.01B
LOGI logo
LOGI
Logitech International SA
13.49B
TTD logo
TTD
Trade Desk Inc
17.09B
PDD logo
PDD
PDD Holdings Inc
150.37B
list 4 promising quantum computing stocks
Intellectia · 294 candidates
Market Cap: >= 500.00MBeta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 0
Ticker
Name
Market Cap$
top bottom
LBRDA logo
LBRDA
Liberty Broadband Corp
6.25B
FRHC logo
FRHC
Freedom Holding Corp
7.61B
CIVI logo
CIVI
Civitas Resources Inc
2.32B
DLO logo
DLO
Dlocal Ltd
3.98B
OWL logo
OWL
Blue Owl Capital Inc
24.58B
CCB logo
CCB
Coastal Financial Corp (EVERETT)
1.73B
what about health tech stocks and robots?
Intellectia · 18 candidates
Market Cap: 50.00M - 50.00BWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ROK logo
ROK
Rockwell Automation Inc
47.26B
SYM logo
SYM
Symbotic Inc
36.98B
TER logo
TER
Teradyne Inc
36.32B
VEEV logo
VEEV
Veeva Systems Inc
36.12B
ZBRA logo
ZBRA
Zebra Technologies Corp
12.31B
DOCS logo
DOCS
Doximity Inc
7.50B
best stocks to invest in for quick growth
Intellectia · 31 candidates
Market Cap: >= 1000.00MQuarter Revenue Yoy Growth: >= 20.0%Quarter Eps Yoy Growth: >= 20.0%Revenue 5yr Cagr: >= 15Eps 5yr Cagr: >= 15
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
TSM logo
TSM
Taiwan Semiconductor Manufacturing Co Ltd
1.69T
AVGO logo
AVGO
Broadcom Inc
1.56T
META logo
META
Meta Platforms Inc
1.54T
LLY logo
LLY
Eli Lilly and Co
1.02T
AMD logo
AMD
Advanced Micro Devices Inc
406.68B

Whales Holding DOCS

R
Rice Hall James & Associates, LLC
Holding
DOCS
+6.92%
3M Return
C
Carmignac Gestion SA
Holding
DOCS
+4.94%
3M Return
T
The Bryn Mawr Trust Company
Holding
DOCS
+1.26%
3M Return
W
William Blair Investment Management, LLC
Holding
DOCS
-2.08%
3M Return
E
E. Öhman J:or Wealth Management
Holding
DOCS
-3.59%
3M Return
F
Fundsmith, LLP
Holding
DOCS
-4.53%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Doximity Inc (DOCS) stock price today?

The current price of DOCS is 24.64 USD — it has decreased -0.56

What is Doximity Inc (DOCS)'s business?

Doximity, Inc. provides a digital platform for the United States medical professionals. It offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.

What is the price predicton of DOCS Stock?

Wall Street analysts forecast DOCS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOCS is42.75 USD with a low forecast of 25.00 USD and a high forecast of 63.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Doximity Inc (DOCS)'s revenue for the last quarter?

Doximity Inc revenue for the last quarter amounts to 185.05M USD, increased 9.76

What is Doximity Inc (DOCS)'s earnings per share (EPS) for the last quarter?

Doximity Inc. EPS for the last quarter amounts to 0.31 USD, decreased -16.22

How many employees does Doximity Inc (DOCS). have?

Doximity Inc (DOCS) has 830 emplpoyees as of March 11 2026.

What is Doximity Inc (DOCS) market cap?

Today DOCS has the market capitalization of 4.55B USD.